You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ECOG score

Showing 26 - 50 of 8,926
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)

Not yet recruiting
  • Non-small-cell Lung Cancer
  • (no location specified)
Jun 8, 2023

Multiple Myeloma, Plasma Cell Leukemia Trial in Shanghai (Human BCMA targeted CAR-NK cells injection)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Human BCMA targeted CAR-NK cells injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Sep 13, 2023

A Real World Study of Regogfinib in HCC

Not yet recruiting
  • Hepatocellular Carcinoma
  • Regorafenib 40 MG
  • (no location specified)
Dec 28, 2022

Chronic Subdural Hematoma Trial (ECoG monitoring)

Not yet recruiting
  • Chronic Subdural Hematoma
  • ECoG monitoring
  • (no location specified)
Jun 9, 2023

Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

Completed
  • Leukemia, Chronic Lymphatic
  • Stuttgart, Baden-Wuerttemberg, Germany
  • +4 more
Nov 24, 2022

Locally Advanced or Metastatic Malignant Solid Tumors Trial in Beijing (WJ05129)

Not yet recruiting
  • Locally Advanced or Metastatic Malignant Solid Tumors
  • Beijing, Beijing, China
    Cancer Institute & Hospital Chinese Academy of Medical Sciences
Apr 6, 2022

Colorectal Cancer, Nursing Trial in Ankara (a Mobile Application)

Recruiting
  • Colorectal Cancer
  • Nursing
  • a Mobile Application
  • Ankara, Çankaya, Turkey
    Ankara Bilkent City Hospital
Apr 12, 2023

Multiple Myeloma Trial in Shanghai, Wenzhou (Human BCMA Targeted T Cells Injection)

Recruiting
  • Multiple Myeloma
  • Human BCMA Targeted T Cells Injection
  • Shanghai, Shanghai, China
  • +1 more
Dec 7, 2022

Baseline Metastases on Clinical Outcomes Among BRAF Positive

Completed
  • BRAF Positive Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis
    Aug 2, 2023

    Primary CNS Lymphoma Trial in Zhengzhou (the dose-escalation phase)

    Recruiting
    • Primary Central Nervous System Lymphoma
    • the dose-escalation phase
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    May 30, 2022

    Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, Pembrolizumab)

    Not yet recruiting
    • Advanced Non-small-cell Lung Cancer
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 12, 2022

    Spinal Cord Injuries Trial in Lausanne (STIMO-BSI system implantation)

    Enrolling by invitation
    • Spinal Cord Injuries
    • STIMO-BSI system implantation
    • Lausanne, Vaud, Switzerland
      CHUV
    Nov 4, 2021

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 16, 2022

    Lung Cancer Trial (Percutaneous or transbronchial argon-helium cryoablation)

    Not yet recruiting
    • Lung Cancer
    • Percutaneous or transbronchial argon-helium cryoablation
    • (no location specified)
    Apr 7, 2023

    Hepatocellular Carcinoma Trial in New Taipei City, Hualien City, Taipei (ATL administration)

    Recruiting
    • Hepatocellular Carcinoma
    • ATL administration
    • New Taipei City, Taiwan (R. O. C.), Taiwan
    • +3 more
    Jun 10, 2022

    Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

    Not yet recruiting
    • Cholangiocarcinoma Non-resectable
    • Cholangiocarcinoma Metastatic
    • (no location specified)
    Oct 10, 2023

    Colorectal Tumors Trial in Beijing (Jianpi Huatan dispensing granule, Placebo granule)

    Recruiting
    • Colorectal Neoplasms
    • Jianpi Huatan dispensing granule
    • Placebo granule
    • Beijing, Beijing, China
      Xiyuan Hospital of China Academy of Chinese Medical Sciences
    Jan 8, 2022

    NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Tirelizumab；Chemotherapy monotherapy
    • (no location specified)
    Jul 27, 2023

    Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)

    Not yet recruiting
    • Long COVID
    • +2 more
    • BrainHQ/Active Comparator Activity
    • +4 more
    • Houston, Texas
    • +1 more
    Aug 1, 2023

    Electrocorticography, Karnofski Index, Glioma Trial in Marseille (ECoG : electrocorticography)

    Terminated
    • Electrocorticography
    • +2 more
    • ECoG : electrocorticography
    • Marseille, Paca, France
      Clairval Private Hospital
    May 16, 2023

    Decompensated Liver Cirrhosis Trial (Human Umbilical Cord Mesenchymal Stem Cells)

    Not yet recruiting
    • Decompensated Liver Cirrhosis
    • Human Umbilical Cord Mesenchymal Stem Cells
    • (no location specified)
    Jul 13, 2023

    Rectal Cancer Trial (NCRT with surgery, or NCT with surgery, or surgery)

    Not yet recruiting
    • Rectal Cancer
    • NCRT with surgery, or NCT with surgery, or surgery
    • (no location specified)
    Jan 3, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma Trial (other, procedure, behavioral)

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Electronic Health Record Review
    • +6 more
    • (no location specified)
    Oct 27, 2023

    Remaxol® in Drug-induced Liver Injuries During Antitumor Therapy

    Recruiting
    • Cancer
    • Drug Induced Liver Injury
    • Krasnoyarsk, Russian Federation
    • +4 more
    Mar 16, 2023

    Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)

    Not yet recruiting
    • Long COVID
    • +2 more
    • BrainHQ/Active Comparator Activity
    • +4 more
    • Houston, Texas
    • +1 more
    Aug 1, 2023